Últimas noticias sobre Insperity (NYSE:NSP) Bolsa

Insperity

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Wall Street

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

ERII

Estas acciones industriales tienen un RSI por debajo de 30: ¿es momento de comprar Energy Recovery, Insperity o Mistras?

3 acciones industriales sobrevendidas con RSI bajo: ¿Oportunidad de compra?

Insperity Inc

NATURALLY SPLNDD ENTPRSE by Naturally Splendid Enterprises Ltd.

Naturally Splendid Enterprises Ltd

ETF Series Solutions Nationwide S&P 500 Risk-Managed Income ETF

9 SPOKES INTL LTD by 9 Spokes International Ltd.

InspireMD Inc

Newron Sport

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Energy Recovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>)</h3>
<ul class="wp-block-list">
<li>On May 7, Energy Recovery reported worse-than-expected first-quarter financial results. The company's stock fell around 28% over the past five days and has a 52-week low of $10.86.</li>
<li>RSI Value: 20.2</li>
<li>ERII Price Action: Shares of Energy Recovery fell 7.2% to close at $11.37 on Friday.</li>
<li>Edge Stock Ratings: 21.95 Momentum score with Value at 53.40.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/ERII"><img loading="lazy" decoding="async" width="502" height="168" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082731/image-117.png" alt="" class="wp-image-911820" style="width:320px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082731/image-117.png 502w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082731/image-117-300x100.png 300w" sizes="(max-width: 502px) 100vw, 502px" /></a></figure>
<h3 class="wp-block-heading">Insperity Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>)&nbsp;</h3>
<ul class="wp-block-list">
<li>On April 29, Insperity reported worse-than-expected first-quarter financial results, cut its FY25 adjusted EPS guidance, and issued second-quarter adjusted EPS guidance below estimates. &#8220;Our first quarter financial results, reflecting macro-economic turbulence and healthcare cost volatility, are in stark contrast with the solid execution of our game plan for building the foundation for future growth acceleration,&#8221; said Paul J. Sarvadi, Insperity chairman and chief executive officer. The company's stock fell around 23% over the past month and<a href="https://www.benzinga.com/quote/NSP"> has a 52-week low</a> of $61.54.</li>
<li>RSI Value: 29.8</li>
<li>NSP Price Action: Shares of Insperity fell 0.7% to close at $65.92 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0512">NSP stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0512"><img loading="lazy" decoding="async" width="927" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082834/image-118.png" alt="" class="wp-image-911822" style="width:651px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082834/image-118.png 927w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082834/image-118-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082834/image-118-768x693.png 768w" sizes="(max-width: 927px) 100vw, 927px" /></a></figure>
<h3 class="wp-block-heading">Mistras Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>)</h3>
<ul class="wp-block-list">
<li>On May 7, Mistras Group reported worse-than-expected first-quarter financial results. Natalia Shuman, President and Chief Executive Officer said, &#8220;Despite the larger than anticipated year-over-year decline in revenue driven by overall market uncertainty, we were nevertheless able to rapidly calibrate costs and expenses down during the first quarter to our revenue level, in order to preserve our operational metrics. With a continued focus on cost and expense management, including a reduction in our administrative support functional costs, and coupled with anticipated revenue growth across all primary industries, we are confident these drivers will provide an improvement in key profitability measures over the remainder of the year.&#8221; The company's stock fell around 16% over the past five days and has a 52-week<a href="https://www.benzinga.com/quote/MG"> low of $7.06</a>.</li>
<li>RSI Value: 28.9</li>
<li>MG Price Action: Shares of Mistras gained 0.4% to close at $7.82 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0512">MG shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0512"><img loading="lazy" decoding="async" width="881" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082923/image-119.png" alt="" class="wp-image-911823" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082923/image-119.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082923/image-119-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12082923/image-119-768x730.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45342900/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-5">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Top 3 Industrials Stocks That May Explode This Month

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>)</h3>
<ul>
<li>Dividend Yield: 3.67%</li>
<li>Truist Securities analyst Tobey Sommer maintained a Hold rating and cut the price target from $82 to $70 on April 30, 2025. This analyst has an accuracy rate of 72%.</li>
<li>JP Morgan analyst Andrew Polkowitz initiated coverage on the stock with an Underweight rating and a price target of $90 on Oct. 22, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 29, Insperity reported worse-than-expected first-quarter financial results and cut its FY25 adjusted EPS guidance.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">NSP news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="886" height="806" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66.png" alt="" class="wp-image-905112" style="width:599px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66.png 886w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044506/image-66-768x699.png 768w" sizes="(max-width: 886px) 100vw, 886px" /></a></figure>
<h3 class="wp-block-heading">Kennametal Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>)</h3>
<ul>
<li>Dividend Yield: 4.04%</li>
<li>Barclays analyst Julian Mitchell maintained an Equal-Weight rating and cut the price target from $24 to $22 on April 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Jefferies analyst Stephen Volkmann downgraded the stock from Buy to Hold and slashed the price target from $40 to $32 on Dec. 6, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Recent News: Kennametal will host its third quarter fiscal year 2025 earnings call on Wednesday, May 7.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest KMT <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="896" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25.png" alt="" class="wp-image-905113" style="width:566px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25.png 896w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044542/image-2-25-768x701.png 768w" sizes="(max-width: 896px) 100vw, 896px" /></a></figure>
<h3 class="wp-block-heading">Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>)</h3>
<ul>
<li>Dividend Yield: 2.49%</li>
<li>Truist Securities analyst Tobey Sommer maintained a Buy rating and cut the price target from $84 to $80 on April 15, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Baird analyst Mark Marcon maintained an Outperform rating and increased the price target from $72 to $79 on June 14, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On March 11, Korn Ferry reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance with its midpoint above estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest KFY <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507"><img loading="lazy" decoding="async" width="917" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67.png" alt="" class="wp-image-905116" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67-300x267.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07044625/image-67-768x684.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Dividends

Price Target

Analyst Ratings

Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) with a Hold and lowers the price target from $82 to $70.

Truist Securities Maintains Hold on Insperity, Lowers Price Target to $70

<h3>Gainers</h3>
<ul>
<li>Clarivate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) shares moved upwards by 16.6% to $4.18 during Tuesday's regular session. The company's market cap stands at $2.8 billion. The company's, Q1 earnings came out today. </li>
<li>Primech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) stock increased by 16.33% to $0.99. The company's market cap stands at $37.7 million. </li>
<li>CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) stock increased by 16.3% to $22.33. The market value of their outstanding shares is at $781.3 million. As per the news, the Q1 earnings report came out today. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares increased by 16.14% to $0.24. The market value of their outstanding shares is at $47.8 million. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) stock moved upwards by 15.15% to $1.52. The market value of their outstanding shares is at $44.3 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) stock moved upwards by 14.55% to $1.81. The market value of their outstanding shares is at $24.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marwynn Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MWYN#NASDAQ">MWYN</a>) shares declined by 28.0% to $2.93 during Tuesday's regular session. The company's market cap stands at $49.9 million. </li>
<li>Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) shares declined by 15.81% to $36.0. The company's market cap stands at $687.9 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) stock fell 15.77% to $2.14. The market value of their outstanding shares is at $257.9 million. </li>
<li>Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) shares declined by 15.22% to $66.65. The market value of their outstanding shares is at $2.5 billion. As per the news, the Q1 earnings report came out today. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares declined by 15.05% to $0.96. The company's market cap stands at $12.3 million. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock fell 14.78% to $0.36. The market value of their outstanding shares is at $19.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMPX

CECO

CLVT

GTEC

KFRC

LNZA

MWYN

Nuveen Insured California Premium Fund Ii

OMEX

PMEC

UAVS

12 Industrials Stocks Moving In Tuesday's Intraday Session

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 250 points on Tuesday.
The Dow traded up 0.70% to 40,507.41 while the NASDAQ rose 0.30% to 17,417.49. The S&amp;P 500 also rose, gaining, 0.37% to 5,548.98.
Check This Out: <a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a>
Leading and Lagging Sectors Materials shares jumped by 0.6% on Monday.
In trading on Monday, consumer discretionary fell by 0.5%.
Top Headline
Shares of Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) gained around 3% on Tuesday after the company reported better-than-expected earnings for its first quarter.
Pfizer posted quarterly earnings of 92 cents per share, beating market estimates of 67 cents per share. The company's quarterly sales came in at $13.71 billion, missing expectations of $13.95 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares shot up 18% to $33.69 after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.</li>
<li>Shares of Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>)got a boost, surging 24% to $9.02 after the company reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance.</li>
<li>WW International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) shares were also up, gaining 86% to $0.7723 after the company announced a pharmacy integration with Eli Lilly&#8217;s LillyDirect pharmacy provider, Gifthealth.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) shares dropped 22% to $7.75 following a first-quarter revenue miss.</li>
<li>Shares of Piedmont Office Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) were down 17% to $5.66 after the company posted first-quarter results.</li>
<li>Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) was down, falling 15% to $66.88 following weaker-than-expected quarterly earnings.</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $60.54 while gold traded down 0.6% at $3,327.80.
Silver traded up 1.6% to $33.545 on Tuesday, while copper fell 0.2% to $4.8780.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 gained 0.21%, Germany's DAX 40 gained 0.55% and France's CAC 40 fell 0.28%. Spain's IBEX 35 Index fell 0.80%, while London's FTSE 100 rose 0.28%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with China's Shanghai Composite falling 0.05%, Hong Kong's Hang Seng Index gaining 0.16% and India's BSE Sensex gaining 0.09%.
Economics
<ul>
<li>The number of job openings in the U.S. declined by 288,000 to 7.192 million in March, compared to market estimates of 7.48 million.</li>
<li>The S&amp;P CoreLogic Case-Shiller Home Price Index increased 4.5% year-over-year in February.</li>
<li>The FHFA house price index increased by 0.1% in February versus a revised 0.3% rise in January.</li>
<li>U.S. wholesale inventories climbed 0.5% month-over-month to $908 billion during March.</li>
<li>The U.S. trade deficit in goods increased to $162 billion in March compared to market estimates of a $146 billion gap. </li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45065334/amazon-com-to-253-here-are-10-top-analyst-forecasts-for-tuesday">Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Commodities

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings

WIIM

Insperity shares are trading lower after the company reported worse-than-expected Q1 financial results, cut its FY25 adjusted EPS guidance, and issued Q2 adjusted EPS guidance below estimates.

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="4" rowspan="1">The following is a reconciliation of GAAP to non-GAAP financial measures for second quarter and full year 2025 guidance:</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Q2 2025</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Full Year 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(in millions, except per share amounts)</td>
<td colspan="1" rowspan="1">Guidance</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net income (loss)</td>
<td colspan="1" rowspan="1">$(3) - $11</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$42 - $81</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Income tax expense (benefit)</td>
<td colspan="1" rowspan="1">(1) - 5</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">17 - 33</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest expense</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">25</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SaaS implementation amortization</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Depreciation and amortization</td>
<td colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">42</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EBITDA</td>
<td colspan="1" rowspan="1">14 - 34</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">130 - 185</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Stock-based compensation</td>
<td colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">60</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$33 - $53</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$190 - $245</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted EPS</td>
<td colspan="1" rowspan="1">$(0.07) - $0.31</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$1.10 - $2.15</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-GAAP adjustments:</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Stock-based compensation</td>
<td colspan="1" rowspan="1">0.50</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">1.59</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Tax effect</td>
<td colspan="1" rowspan="1">(0.14)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(0.46)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total non-GAAP adjustments, net</td>
<td colspan="1" rowspan="1">0.36</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">1.13</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">$0.29 - $0.67</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.23 - $3.28</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Insperity Q2 Adj EPS Outlook $0.29-$0.67 vs $0.69 Estimate

Insperity Lowers FY25 Adj EPS Guidance From $3.10-$3.95 To $2.23-$3.28 vs $3.47 Estimate

Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) reported quarterly earnings of $1.57 per share which missed the analyst consensus estimate of $2.02 by 22.28 percent. This is a 30.84 percent decrease over earnings of $2.27 per share from the same period last year. The company reported quarterly sales of $1.86 billion which missed the analyst consensus estimate of $1.87 billion by 0.15 percent. This is a 3.39 percent increase over sales of $1.80 billion the same period last year.

Earnings Misses

Insperity Q1 Adj. EPS $1.57 Misses $2.02 Estimate, Sales $1.86B Miss $1.87B Estimate

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CHCT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement.
Analysts estimate that Insperity will report an earnings per share (EPS) of $2.02. 
The market awaits Insperity's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.03, leading to a 5.7% increase in the share price the following trading session.
Here's a look at Insperity's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.02</td>
<td>0.33</td>
<td>0.72</td>
<td>2.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.05</td>
<td>0.39</td>
<td>0.86</td>
<td>2.27</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>-5.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745863268_0.png" alt="eps graph" />
<h3>Performance of Insperity Shares</h3>
Shares of Insperity were trading at $79.0 as of April 25. Over the last 52-week period, shares are down 24.74%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analysts' Perspectives on Insperity</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Insperity.
Insperity has received a total of 1 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $82.0, the consensus suggests a potential 3.8% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Alight, Korn Ferry and First Advantage, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Alight, with an average 1-year price target of $9.75, suggesting a potential 87.66% downside.</li>
<li>Analysts currently favor an Buy trajectory for Korn Ferry, with an average 1-year price target of $80.0, suggesting a potential 1.27% upside.</li>
<li>Analysts currently favor an Outperform trajectory for First Advantage, with an average 1-year price target of $19.0, suggesting a potential 75.95% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Alight, Korn Ferry and First Advantage, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Insperity</td>
<td>Neutral</td>
<td>2.09%</td>
<td>$218M</td>
<td>-8.11%</td>
</tr>
<tr>
<td>Alight</td>
<td>Buy</td>
<td>-0.29%</td>
<td>$271M</td>
<td>0.19%</td>
</tr>
<tr>
<td>Korn Ferry</td>
<td>Buy</td>
<td>-0.05%</td>
<td>$165.36M</td>
<td>3.23%</td>
</tr>
<tr>
<td>First Advantage</td>
<td>Outperform</td>
<td>51.62%</td>
<td>$138.63M</td>
<td>-9.01%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Insperity ranks at the bottom for Revenue Growth and Gross Profit, with negative percentages. It also has the lowest Return on Equity among its peers. However, it is rated as Neutral, which is better than being rated as Outperform or Buy.
<h3>Unveiling the Story Behind Insperity</h3>
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
<h3>Unraveling the Financial Story of Insperity</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Insperity's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 2.09%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Insperity's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -0.56%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Insperity's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -8.11%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Insperity's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.4%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Insperity's debt-to-equity ratio stands notably higher than the industry average, reaching 4.48. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/NSP/earnings">To track all earnings releases for Insperity visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look at Insperity's Upcoming Earnings Report

Truist Securities analyst Tobey Sommer maintains Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) with a Hold and lowers the price target from $88 to $82.

Truist Securities Maintains Hold on Insperity, Lowers Price Target to $82

U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on Monday.
Shares of Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) rose sharply during Monday's session after Rocket Companies announced it will acquire the company in an all-stock transaction valued at $12.50 per share.
Under the terms of the agreement, Redfin shareholders will receive 0.7926 shares of Rocket Class A common stock for each Redfin share—a 63% premium over Redfin&#8217;s 30-day volume-weighted average price. Rocket shareholders will own approximately 95% of the combined company upon completion, with Redfin shareholders holding the remaining 5%.
Redfin shares jumped 70% to $9.89 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Mineralys Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) gained 53% to $16.09 after the company reported topline data from its pivotal LAUNCH-HTN Phase 3 and ADVANCE-HTN Phase 2 trials of Lorundrostat for hypertension. Both trials met the primary endpoint.</li>
<li>Trevi Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) surged 41.8% to $6.10 after the company reported topline results from its Phase 2a RIVER trial of Haduvio for RCC, which met the primary endpoint.</li>
<li>Protagonist Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) rose 41% to $54.08 after the company announced topline results from its Phase 2b ANTHEM-UC study of icotrokinra in ulcerative colitis. The study met its primary endpoint in all dose groups evaluated.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) gained 17.7% to $14.18.</li>
<li>Veren Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRN#NYSE">VRN</a>) gained 15.6% to $5.68 after the company announced a $15 billion strategic merger with Whitecap to form a leading oil producer.</li>
<li>WK Kellogg Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) rose 9.3% to $21.91.</li>
<li>Dave &amp; Buster&#8217;s Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) gained 8.9% to $21.02.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) rose 8.4% to $76.61.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) gained 8.2% to $29.53. Kratos said its OpenEdge 2500 achieved DIFI compliance.</li>
<li>STAAR Surgical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) rose 7.2% to $19.66.</li>
<li>Harley-Davidson, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>) gained 6.9% to $27.90.</li>
<li>Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) climbed 5.5% to $52.16.</li>
<li>Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) shares rose 5.4% to $95.24.</li>
<li>Tractor Supply Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) gained 4.6% to $59.54.</li>
<li>The Campbell&#8217;s Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) rose 4.4% to $43.65.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

Intraday Update

KTOS

LZMH

MLYS

PLAY

PTGX

RDFN

STAA

TRVI

TSCO

Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares rocketed 97.62% after NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) disclosed a stake of 1.74 million shares in a 13F filing.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) stock escalated 43.45%, probably after President Trump had reportedly postponed tariffs on packages under $800 from China. Additionally, optimism towards China&#8217;s DeepSeek AI model has also lifted stocks recently.</li>
<li>SpringWorks Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) shares jumped 42.58% after announcing Merck KGaA (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKGAF#OTC">MKGAF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKKGY#OTC">MKKGY</a>) is in advanced <a href="https://www.benzinga.com//node/43631130" target="_blank" rel="noreferrer noopener">discussions to acquire the company</a>.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) shares increased 40.59%.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) stock upped 39.09%.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares rose 28.23%  after the company announced UltraRapid Whole Genome Sequencing, which will deliver actionable <a href="https://www.benzinga.com//node/43692155" target="_blank" rel="noreferrer noopener">results within 48 hours</a>.</li>
<li>VNET Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) stock upped 28.22%, probably amid a possible rebound after falling last week due to AI competition concerns related to China&#8217;s DeepSeek AI model.</li>
<li>Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) stock increased 25.99% after the company reported better-than-<a href="https://www.benzinga.com//node/43590222" target="_blank" rel="noreferrer noopener">expected fourth-quarter results</a>.</li>
<li>CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) stock grew 25.21% after the company reported better-than-<a href="https://www.benzinga.com//node/43639785" target="_blank" rel="noreferrer noopener">expected fourth-quarter financial results</a>. Several analysts raised the price <a href="https://www.benzinga.com/quote/crsp/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast on the stock</a>.</li>
<li>Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) stock grew 24.01% after the company reached a settlement agreement with Teva Pharmaceutical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>), resolving all patent <a href="https://www.benzinga.com//node/43601535" target="_blank" rel="noreferrer noopener">litigation related to its Auvelity product</a>. Several analysts raised <a href="https://www.benzinga.com/quote/axsm/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
</ol>
Photo via WeRide

Mid Cap

AXSM

CRSP

MKGAF

MKKGY

NVDA

RXRX

SWTX

TEVA

VNET

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?

It was reported on February 13, that ARTHUR ARIZPE, President and COO at Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) executed a significant insider sell, according to an SEC filing.
What Happened: ARIZPE's decision to sell 6,000 shares of Insperity was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001000753/000112760225004647//Archives/edgar/data/1000753/000112760225004647/0001127602-25-004647-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $508,108.
At Friday morning, Insperity shares are up by 0.61%, trading at $86.8.
<h3>Unveiling the Story Behind Insperity</h3>
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
<h3>Financial Insights: Insperity</h3>
Revenue Growth: Insperity's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 0.64%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 14.67%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Insperity's EPS is below the industry average. The company faced challenges with a current EPS of 0.07. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.48, caution is advised due to increased financial risk.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 35.65, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.5, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 13.09, Insperity presents an attractive value opportunity.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Exploring Key Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001000753">Check Out The Full List Of Insperity's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

President and COO Of Insperity Makes $508K Sale

Wall Street bounced back on Monday, recovering from Friday's robust decline fueled by tariff concerns, as investors remained focused on strong earnings from the fourth-quarter reporting season while awaiting further <a href="https://www.benzinga.com/government/regulations/25/02/43596413/corporate-americas-best-earnings-in-3-years-will-tariffs-end-wall-streets-honeymoon">clarity on trade policies.</a>
The Nasdaq 100 jumped 1.3% by midday in New York, poised for its best session in over three weeks, with semiconductor stocks leading the charge. 
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) gained 3.4%, buoyed by a Wall Street Journal <a href="https://www.wsj.com/articles/new-york-state-bans-deepseek-from-government-devices-de7a9df4">report</a> announcing that New York State banned DeepSeek from government devices, sparking speculation about stricter state regulations on Chinese AI chip products.
Steel and aluminum stocks rallied after President Donald Trump announced plans to impose a 25% tariff on imports of both <a href="https://www.benzinga.com/government/regulations/25/02/43592144/us-steel-aluminum-stocks-rally-as-trump-revives-25-tariff-plan">metals from all countries.</a>
<ul>
<li>United States Steel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) rose 4.7%, eyeing its best session in a month.</li>
<li>Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) climbed 5.5%.</li>
<li>Century Aluminum Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) jumped 10.4%, while Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) gained 6.5%.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) soared 17.3%, Alcoa Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) rose 3.6%, and Kaiser Aluminum Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) added 2.9%.</li>
</ul>
Commodities rallied, with metals and energy producers outperforming. Gold extended record highs with a 1.5% gain, but copper stole the spotlight, surging 2.6% to its highest level since May 2024, marking its sixth consecutive daily gain. Oil prices also rebounded, rising over 1%.
Crypto sentiment improved slightly, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) gaining 1% to $97,500 after a period of subdued price action.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-day %change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,778.76</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,069.92</td>
<td>0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,291.54</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,437.68</td>
<td>0.3%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;rose 0.7% to $604.81.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) inched 0.3% up to $444.50.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rallied 1.3% to $529.73.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.6% to $227.25.</li>
<li>The&nbsp;Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 2%; the&nbsp;Financials Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 0.7%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
Stocks reacting to earnings reports included:
<ul>
<li>McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>): up 3.8%</li>
<li>Rockwell Automation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>): up 12.8%</li>
<li>ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>): down 6.6%</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>): up 30.3%</li>
<li>Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>): up 14.7%</li>
<li>Edgewell Personal Care Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>): down 9.7%</li>
<li>CNA Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>): up 2.1%</li>
<li>Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>): down 6.0%</li>
<li>Roivant Sciences Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>): up 1.1%</li>
<li>GCM Grosvenor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCMG#NASDAQ">GCMG</a>): up 3.8%</li>
<li>PowerFleet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>): up 32.3%</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43600852/china-sets-sights-on-us-tech-companies-as-trade-tensions-rise">China Sets Sights On Apple, Nvidia And Other US Tech Companies As Trade Tensions Rise</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Macro Economic Events

Regulations

Econ #s

Economics

Tech

ETFs

$BTC

AIOT

CENX

SPDR Dow Jones Industrial Average ETF Trust

GCMG

KALU

MNDY

ROIV

STLD

Select Sector SPDR-Consumer Discretionary

Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?

U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Monday.
Shares of Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) rose sharply during Monday's session after the company reported <a href="https://in.benzinga.com/25/02/43596322/rockwell-automation-q1-results-defie-sales-decline-with-higher-margins-and-strong-cash-flow">first-quarter earnings above estimates.</a>
Rockwell Automation said sales fell 8.4% year over year and slid 7.6% organically to $1.881 billion, in line with the consensus of $1.881 billion. Total ARR grew 11%. Adjusted EPS was $1.83 (-10% YoY), above the analyst consensus of $1.59.
Rockwell Automation shares jumped 10.5% to $296.78 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>SpringWorks Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) shares jumped 30.2% to $52.45 after announcing Merck KGaA is in advanced discussions to acquire the company.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) gained 28.8% to $332.78 after the company reported better-than-expected fourth-quarter financial results and first-quarter revenue outlook.</li>
<li>PowerFleet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) rose 24.2% to $7.39 after the company reported better-than-expected Q3 sales results and raised its FY25 sales and adjusted EBITDA guidance.</li>
<li>Satellogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) gained 22.4% to $4.5200.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) climbed 18.8% to $31.50.</li>
<li>Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) rose 18.8% to $125.70 after the company reached a settlement agreement with Teva Pharmaceuticals resolving all patent litigation related to its Auvelity product.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) gained 16.2% to $18.67 after B of A Securities upgraded the stock from Underperform to Neutral and raised its price target from $12 to $19.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 15% to $21.50. Shares of steel and aluminum stocks traded higher after reports President Trump plans additional 25% tariffs on steel and aluminum.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) gained 11.6% to $11.19. Shares of steel and aluminum stocks traded higher after reports President Trump plans additional 25% tariffs on steel and aluminum.</li>
<li>Insperity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) rose 11.4% to $77.51 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Light &amp; Wonder, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) rose 11% to $97.64.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) surged 6.7% to $90.85.</li>
<li>BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) rose 6.3% to $34.32 after a report from The Wall Street Journal said Elliott Management has built a stake in the company and will push for changes.</li>
<li>Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) gained 6.1% to $109.84 after President Trump reportedly postponed tariffs on packages under $800 from China.</li>
<li>United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) rose 5.5% to $38.99.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

ASTS

BABA

MBLY

ROKU

SATL

Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday

Insperity shares are trading higher after the company reported better-than-expected Q4 financial results.

The Q4 earnings report for Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) was released on Monday, February 10, 2025 at 08:00 AM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Insperity beat estimated earnings by 150.0%, reporting an EPS of $0.05 versus an estimate of $0.02.
Revenue was up $33.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.06 in the last quarter, resulting in a 5.0% drop share price change the following day.
Here's a look at Insperity's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.33</td>
<td>0.72</td>
<td>2.12</td>
<td>0.64</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.39</td>
<td>0.86</td>
<td>2.27</td>
<td>0.75</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.56B</td>
<td>1.62B</td>
<td>1.81B</td>
<td>1.58B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.56B</td>
<td>1.60B</td>
<td>1.80B</td>
<td>1.58B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Insperity management provided guidance for Q1 2025, expecting earnings between $1.89 and $2.15 per share.
To track all earnings releases for Insperity <a href="https://www.benzinga.com/quote/NSP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insperity Q4 Earnings Report: What Investors Need to Know

Insperity Sees FY25 Adj EPS Of $3.10 - $3.95 Vs. $3.67 Est; Q1 Adj EPS Of $1.89 - $2.15 Vs. $2.02 Est.

Press Releases

Inc. Names Insperity as a 2024 Power Partner Award Winner

Insperity Announces Third Quarter Results

Insperity Declares Quarterly Dividend of $0.60

Insperity Announces Talent Strategy Research

Insperity Fourth Quarter Earnings Conference Call Monday, February 10

Insperity Announces Fourth Quarter and Full Year 2024 Results

Insperity First Quarter Earnings Conference Call Tuesday, April 29

Insperity Announces First Quarter Results

Automatic Data Processing, Inc. - Common Stock

Automatic Data Processing

Alight

Asure Software

Barrett Business Services, Inc. - Common Stock

Barrett Business Services

Baiya International Group Inc. - Ordinary Shares

Baiya International Group

Dayforce

DLH Holdings

First Advantage Corporation - Common Stock

First Advantage

Fiverr International Ltd. Ordinary Shares, no par value

Fiverr Intl

HireQuest

Heidrick & Struggles International, Inc. - Common Stock

Heidrick & Struggles Intl

Kelly Services, Inc. - Class A Common Stock

Kelly Services

Kforce

Comments

Insperity

Noticias

Últimas noticias sobre Insperity (NYSE:NSP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL